产品
编 号：F745290
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
结构图
CAS No: 1448221-05-3
产品详情
生物活性：
Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects.
体内研究：
Vanucizumab (20mg /kg;i.p。每周1次;6周) 显示肿瘤生长抑制和诱导肿瘤停滞。Animal Model:SCID beige mice bearing Colo205 cells
Dosage:20 mg/kg
Administration:i.p.; once weekly; for 6 weeks
Result:Showed tumor growth inhibition.
Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects.
体内研究：
Vanucizumab (20mg /kg;i.p。每周1次;6周) 显示肿瘤生长抑制和诱导肿瘤停滞。Animal Model:SCID beige mice bearing Colo205 cells
Dosage:20 mg/kg
Administration:i.p.; once weekly; for 6 weeks
Result:Showed tumor growth inhibition.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备